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ABSTRACT
With the availability of a large amount of genomic
data it is expected that the influence of single
nucleotide variations (SNVs) in many biological phe-
nomena will be elucidated. Here, we approached the
problem of how SNVs affect alternative splicing.
First, we observed that SNVs and exonic splicing
regulators (ESRs) independently show a biased dis-
tribution in alternative exons. More importantly,
SNVs map more frequently in ESRs located in alter-
native exons than in ESRs located in constitutive
exons. By looking at SNVs associated with alterna-
tive exon/intron borders (by their common presence
in the same cDNA molecule), we observed that a
specific type of ESR, the exonic splicing silencers
(ESSs), are more frequently modified by SNVs. Our
results establish a clear association between
genetic diversity and alternative splicing involving
ESSs.
INTRODUCTION
The large amount of data on the human transcriptome has
allowed several studies that, without exception, show a
high prevalence of alternative splicing in the human tran-
scriptome (1–3). The fact that most human genes undergo
alternative splicing has raised doubts about the biological
signiﬁcance of most of the variants. One possibility is that
a signiﬁcant fraction of all variants are spurious products
of the splicing machinery, without any functional rele-
vance. Indeed, there are signiﬁcant differences (e.g. the
preservation of codon reading frame) between splicing
variants that are conserved between human and mouse,
and therefore deemed as functional, and those that are
not, suggesting that a fraction of the splicing variants
are spurious products (4). Some authors have even sug-
gested that these products would have functional implica-
tions by down-regulating the expression of functional
variants (5). On the other hand, some have argued that
most of the splicing variants are products of a regulated
process. For instance, Wang,E. et al. (6) observed that
most of the splicing variants of human genes show
differential expression among different tissues whereas
variation between individuals was  2 to 3-fold less
common. These results corroborate the hypothesis that
alternative transcripts could have tissue speciﬁc
functionalities. It has also been shown by our group that
intron retention events are not randomly distributed re-
garding several parameters, again suggesting the notion
that the majority of these splicing variants are not
spurious and their expression is somehow regulated
(7,8). Based on the current evidence it is reasonable to
speculate that at least one third of all splicing variants
are products of regulated expression.
In addition to the importance of 50/30-splicing sites,
branch point and polypyrimidine tracts in the control of
splicing, there are several known cis-regulatory splicing
elements that contribute to the splicing process and are
located in intronic or exonic regions [for a review see
(9,10)]. Many lines of evidence suggest that these
elements can act by stimulating (enhancing) or inhibiting
(silencing) the inclusion of the respective exon, or the
neighbor exon, in the mature RNA transcript. These
features are taken into account for the nomenclature of
splicing regulatory elements. Those present in exons and
with the capacity of enhancing splicing are called exonic
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inhibiting the splicing are the exonic splicing silencers
(ESS). Generally, these classes of elements are called
exonic splicing regulators (ESRs).
Several studies suggest that ESS have a signiﬁcant role
in the control of alternative splicing. For example, (i)
using a set of paralogous exons, where one copy showed
constitutive splicing and the other alternative splicing,
Zhang,Z. et al. (11) found that the alternative copy had
signiﬁcantly lower ESE and higher ESS densities than the
constitutive copy; (ii) using designed exons constructed by
random ligation of ESEs, ESSs and neutral sequences,
Zhang,X. et al. (12) showed that negative correlation
between ESS density and inclusion rate was stronger
than the positive correlation between ESE density and
inclusion rate; (iii) The set of motifs which bind the
tissue-speciﬁc splicing factors Nova1 and Nova2 can act
as ESEs or ESS depending on their position in the primary
transcript. When located in alternative exons they mainly
act as silencers (13).
In the present study we used single nucleotide variation
(SNV) and cDNA data to compare the genetic diversity of
ESRs located in constitutive and alternative exons. By
establishing an association between the SNV alleles and
distinct borders of alternative exons our results show that
variations in ESSs, and not in ESEs, are more commonly
associated with alternative splicing.
MATERIALS AND METHODS
Public data
We obtained genomic (build 36.1) and cDNA (mRNAs
and ESTs) sequence data from UCSC Genome Browser
(http://genome.ucsc.edu/, ﬁles: mrna.fa.gz and est.fa.gz).
Additional sequences were obtained from NCBI
Reference Sequence Project (http://www.ncbi.nlm.nih
.gov/RefSeq, release 22). We also downloaded EST
libraries annotation from eVOC (http://www
.evocontology.org/).
Identiﬁcation of splicing events
A catalog of all splicing variants reported by the align-
ment of cDNAs on the human genome was obtained as
previously described (7,8,14,15). Brieﬂy, the coordinates
of exon/intron borders for all cDNAs mapped onto the
human genome were compared against each other to
identify all splicing variants for all human genes. We
used the software SIM4 (http://globin.cse.psu
.edu/html/docs/sim4.html) for a more reﬁned deﬁnition
of the exon/intron borders. To increase the reliability of
splicing events identiﬁed, we have chosen for further
analysis only those events supported by at least two
ESTs from two distinct libraries.
Exon classiﬁcation
The deﬁnition of exonic and intronic regions was based on
the genomic coordinates of cDNA sequences classiﬁed as
‘mRNA’ in GenBank. Regarding alternative splicing, four
groups of exons were deﬁned for the current analyses:
exons reporting different donor or acceptor sites formed
the Cryptic group (alternative splice site, 35391 exons),
exons missing in two or more transcripts formed the
Skipping group (46586 exons) and exons reporting an
intron retention formed the Retention group (8310
exons). These three groups represent the major forms of
alternative splicing. A fourth group, named Alternative
(60383 exons), was formed by the union of the three
groups of alternative exons mentioned above excluding re-
dundant exons among these groups. Finally, the
Constitutive group (70801 exons) was composed by exons
for which no alternative exon/intron borders were detected.
Mapping the ESRs in exons
Eight different data sets of putative regulatory elements
(six ESEs and two ESSs) were obtained from the literature
(16–21). Four (SF2_IgM, SRP40, SRP55 and SC35) out
of six ESE data sets were discovered in vitro by using the
SELEX methodology while the other two were discovered
in silico. Regarding the SELEX-ESEs, only those oligo-
mers with a score equal or higher than the threshold scores
deﬁned by the original study were considered as ESEs. For
the remaining data sets of ESEs (RESCUE and PESE), a
list of ESE motifs was obtained from the supplementary
material associated with the articles of Fairbrother et al.
(18) and Zhang and Chasin (19). The PESS data set of
silencers was also obtained from Zhang and Chasin (19)
and the data set of ESS reported by Wang,Z. et al. (20)
will be called ESS herein.
To identify the ESR motifs in the exons of our in-house
database we perform a pairwise alignment between each
set of ESRs and the exon sequences. The ESR counts were
calculated independently for each group of exons analyzed
in this study (Constitutive, Alternative, Cryptic, Skipping
and Retention).
Mapping SNVs in exons
To make sure the SNVs were correctly indexed in our
exon database, we mapped all 17804036 SNVs available
in the dbSNP (release 130) in the genomic sequences used
for our analysis. Relative positions of SNVs regarding
exonic, intronic and intergenic regions were deﬁned by
comparing SNV cDNA coordinates.
Mapping exonic SNVs in published ESRs motifs
Sequence tags comprising each SNV were generated by
extracting from the reference human genome the corres-
ponding variant nucleotide plus ten nucleotides ﬂanking
the SNVs (totaling a 21 nucleotide tag, which we will be
called SNP-tag herein). We only extracted tags from the
same strand orientation of the Refseq gene which contains
the exon where the SNV was mapped. The alignment of
these tags with the published ESR motifs deﬁned whether
or not the SNV was mapped into a known ESR.
Finding isoform-associated SNVs and deﬁning putative
ESR motifs
Alignments between all human mRNAs and the genome
were searched for the presence of mismatches.
Nucleic Acids Research, 2011,Vol.39, No. 12 4943The position of the mismatches was then compared to the
genomic position of SNVs. These analyses resulted in
106271 mismatches that that co-occur with SNVs. For
96756 of these mismatches, the discordant nucleotide
reported by the mRNA corresponded to one of the
alleles reported in the dbSNP for the respective SNV.
Since the mRNA sequences are supposedly of high
quality, this last number strongly suggests that the great
majority of mismatches reported in the alignments are due
to SNVs. Among these mismatches we selected 3533 SNVs
where each allele was completely associated with alterna-
tive exon/intron borders (we refer to these as
isoform-associated SNVs). Considering all the alleles of
these SNVs, we obtained 7087 sequence tags (17 tri-allelic
and 2 quadri-allelic SNVs). SNVs that presented the same
allele in cDNAs reporting different exon/intron borders
were not included in the category of isoform-associated
SNVs.
To make statistical inferences about a possible enrich-
ment of known regulatory elements in the isoform-
associated SNV data set, we randomly created 1000
control data sets from a pool of 46336 SNVs also
mapped in alternative exons but without alleles in
complete association with alternative exon/intron
borders. A schematic view of our approach is shown in
Figure 1. Distinct control data sets were created for the
three main groups of alternative exons (Cryptic, Retention
and Skipping). Each control data set is of exactly the same
size as the isoform-associated SNV data set (1385 SNVs
for Cryptic, 1780 SNVs for Retention and 958 SNVs for
Skipping). Similarly, we create control data sets, with 3533
SNVs each, to use in the comparison with the main group
of alternative exons (which includes all three forms of
alternative exons). Next, we used the same strategy
described above to generate tags around the SNVs of
the control data sets and search for known ESR motifs.
For each replicate data set we counted the number of
ESRs that were part of an SNP-tag, and used the distri-
bution of these values to test the null hypothesis that our
set of isoform-associated SNVs are not associated with
ESRs. The P-value was deﬁned as the fraction of the
ranked values observed in the control data sets which
were greater than the observed value in the case set.
Deﬁning the ancestral and derived alleles of SNVs
In order to establish the polarity of the ESR modiﬁcation
imposed by SNVs and so deﬁne events as gains, losses or
maintenance/alteration of ESRs, we compared the alleles
of human SNVs to the orthologous alleles of the chimpan-
zee (Pan troglodytes) genome. To perform this analysis we
used data from the table ‘snp130OrthoPt2Pa2Rm2’ avail-
able at the UCSC Genome Browser (http://genome.ucsc
.edu/), which contains the othologs of 11797184 human
SNVs in four species of primates, including the
chimpanzee.
Statistical test
For all comparisons of proportions presented in this
article we used the chi-square distribution to evaluate
the statistical signiﬁcance of the difference between the
expected and observed values. We used the chi-square
Figure 1. Schematic representation of the computational approach used in this study to identify splicing regulatory elements. (a) Isoform-associated
SNVs. Schematic view of association between genetic and splicing variation. A sine qua non condition is the presence of both the SNV and the
alternative exon/intron border in the same cDNA molecule allowing the direct association between the alternative exon/intron border and the
presence of the SNV. (b) Control. Schematic view of SNVs not associated with splicing variation, which deﬁned the control set used in
the simulation.
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software (http://www.r-project.org/).
RESULTS AND DISCUSSION
Alternative exons are enriched in SNVs when compared to
constitutive exons
We ﬁrst compared the density of SNVs between constitu-
tive and alternative exons. Alternative exons, when taken
as an unique group, have  10% more SNVs than consti-
tutive exons (5.09 and 4.52 SNVs per 1000 nucleotides
for alternative and constitutive exons, respectively,
P-value=2.53
 102, chi-square test).
Comparisons among three sub-groups of alternative
exons reveals that the Skipping group shows a signiﬁ-
cantly lower SNV density than the other two groups.
(Skipping=5.01 versus Cryptic=5.19 and
Retention=5.17 SNVs per 1000 nucleotides, P-value
<3.81
 9 for both comparisons). This reduced genetic di-
versity of skipped exons in relation to other forms of al-
ternative exons may reﬂect a stronger selective constraint.
This result is in accordance with the ﬁndings from
Wang,E. et al. (6), who showed that skipped exons are
more conserved among four mammalian genomes and
seem to be most important in tissue-speciﬁc alternative
splicing.
Alternative exons are enriched in ESRs when compared
to constitutive exons
Next, the density of ESRs was compared between consti-
tutive and alternative exons. Table 1 shows that ESR
motifs are enriched in the group of alternative exons.
RESCUE-ESEs and PESEs were the exceptions, present-
ing an opposite trend. These exceptions are, in fact,
expected since RESCUE-ESEs are identiﬁed from a set
of constitutive exons and PESEs are identiﬁed from a set
of exons with high inclusion levels (18,19).
Exons belonging to the Skipping group showed a sig-
niﬁcant depletion in the density of SELEX-ESEs and ESSs
when compared to the other groups of alternative exons
(Figure 2). These results corroborate the results of
Kurmangaliyev and Gelfand (22), who observed similar
results in a comparison between skipped exons and
exons with alternative splicing sites with mutations in
their splice sites. However, they contradict the ﬁndings
from Wang,J. et al. (23), who performed a similar
analysis and found a signiﬁcantly lower density of
SELEX-ESEs in skipped exons when compared to consti-
tutive exons. We believe that the discrepancy between our
result and those of Wang,J. et al. (23) may be due to
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Figure 2. Comparison of ESR density between the three main types of alternative exons. Values represent the log10 of the ratio between each
individual group of alternative exons and the Alternative group (pool of the three types).
Table 1. Comparison of ESR density between constitutive and alter-
native exons
ESR Constitutive
(10650372)
Alternative
(22622280)
Percent
change
#
P-value*
RESCUE 0.11305 0.08943  20.8 0
SF2_IgM 0.05466 0.06135 12.2 0
SC35 0.04156 0.04534 9.0 0
SRP40 0.04275 0.04400 2.8 6.97
 61
SRP55 0.02514 0.02530 0.06 0.01
PESE 0.07030 0.06398  8.9 0
PESS 0.01430 0.01916 33.9 0
ESS 0.00006 0.00013 116.6 2.76
 59
*P-value for two-tailed chi-square test. Between brackets is the total
number of nucleotides analyzed in each exon group.
#Approximate
percent change of Alternative compared with Constitutive exons.
Positive and negative values represents excess and depletion, respectively.
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studies. Currently, the coverage of the human transcrip-
tome is deeper when compared to 2005, and probably a
signiﬁcant proportion of exons deﬁned as constitutive in
their work is currently deﬁned as alternative.
Alternative exons show higher proportion of ESRs
modiﬁed by a SNV than constitutive exons
We next compared the proportion of ESRs modiﬁed by a
SNV in both constitutive and alternative exons. Generally,
ESRs in alternative exons are proportionally more
modiﬁed by a SNV than those ESRs in constitutive
exons (P-value <1.26
 16, chi-square test, highest signiﬁ-
cant P-value from Table 2). The only exception was for
ESS. Despite the fact that PESE and RESCUE sets are
enriched in constitutive exons, we also observed a higher
proportion of these motifs mapped in SNVs of alternative
exons than in SNVs of constitutive exons. Moreover, these
two sets of ESRs showed the most signiﬁcant differences
in comparisons between constitutive and alternative exons
(Table 2). Consistent with our previous observations, the
Skipping group showed the lowest proportion of ESRs
affected by SNVs among the groups of alternative exons
(Supplementary Table S5).
The observations that the alternative exons show a
higher density of SNVs, ESRs and also a higher propor-
tion of ESRs modiﬁed by SNVs, suggest that this genetic
variation could to some extent be one of the causal factors
distinguishing alternative and constitutive splicing. In fact
several studies analyzed the impact of single nucleotide
polymorphism in the regulation of transcript isoform ex-
pression in tissue-speciﬁc and non-speciﬁc manners
(24–26) and validated some causative SNPs occurring in
splicing regulators (27).
ESS associated with alternative splicing are more
modiﬁed by SNVs
We decided to further explore this putative association
between the SNVs and alternative splicing by examining
those cDNAs that reported both an alternative exon/
intron border and known SNV. Two categories of SNVs
were used. The ﬁrst category contains SNVs with alleles in
complete association with different exon/intron borders
(isoform-associated SNVs). The second category, the
control set, contains the remaining SNVs mapped to
alternative exons, i.e. those SNVs without a complete
association with alternative exon/intron borders
(Figure 1).
Among the set of sequence tags derived from the
isoform-associated SNVs we found that  86% contained
at least one ESR already described. Is there an enrichment
of any particular type of ESR in this set of sequence tags
in comparison to tags derived from SNVs not associated
with alternative borders? To answer this question,
re-sampling was performed comparing the isoform-
associated SNV data set to 1000 control data sets, each
comprised of the same number of SNVs but not associated
with alternative exon/intron borders. The analysis was
performed independently for each set of published ESRs
using alternative exons either as an unique group or
divided into the three categories previously discussed.
Table 3 shows that isoform-associated tags are enriched
in ESSs in comparison with the control data set when the
alternative exons are analyzed as an unique group. This is
true for both sets of ESS analyzed (PESS and ESS).
Moreover, the isoform-associated SNVs is signiﬁcantly
depleted in ESEs when compared to the replicate data
sets (Table 3). Interestingly, Zhang,X. et al. (12), showed
that the absolute number of ESS correlates signiﬁcantly
(R
2=0.78, P-value<5
 47) with the non-inclusion rate
(negative correlation with inclusion rate) of exons,
when other splicing signals are constant. Moreover, they
found a signiﬁcant positive correlation (R
2=0.53,
P-value<3e
 6) between inclusion level and the ratio
ESE/ESE+ESS. Consistent with this, we found this
ratio to be signiﬁcantly lower in the SNP-tags of our ex-
perimental data set when compared to the SNP-tags of
control data sets (data not shown). Together, these
results suggest that the inﬂuence of SNVs on some types
of alternative splicing occur predominantly through their
effects on ESSs.
A recent study by Woolfe et al. (28), analyzed a small
set of well curated SNPs (a total of 87) associated to exon
skipping, which they compared to a large set of HapMap
SNPs which were putatively neutral with respect to
splicing. Using an approach different from ours, they
also found that alterations of ESSs were signiﬁcantly
overrepresented when compared to alterations which are
putatively neutral with respect to splicing. Moreover, they
also found that the degree of ESS alterations was even
greater for events of alternative splice site than that for
exon skipping. The concordance between these two
studies, which used different approaches to deﬁne the as-
sociation between SNVs and splicing variants, corrobor-
ates the important role played by ESSs in the splicing
regulation.
Analyzing the polarity of the ESRs changes imposed
by SNVs
Can we further discriminate the effect of SNVs in ESSs? If
we assume that the derived allele increases transcriptome
variability by allowing the use of alternative exon/intron
Table 2. Proportion of ESRs affected by SNVs in both Constitutive
and Alternative exons
ESR Constitutive Alternative Percent
change
#
P-value*
RESCUE 0.03900 0.04614 18.3 1.72
 203
SF2_IgM 0.07658 0.08064 5.3 7.82
 22
SC35 0.07341 0.08319 13.3 3.95
 89
SRP40 0.06326 0.06889 8.9 2.69
 36
SRP55 0.06240 0.06721 7.7 1.26
 16
PESE 0.05819 0.06800 16.8 6.82
 173
PESS 0.05858 0.06724 14.7 4.87
 32
ESS 0.12006 0.11569  3.6 0.8
Proportions were obtained by dividing the number of ESRs affected by
a SNV by the total of ESRs, within each group.
*P-value for two-tailed chi-square test.
#Approximate fold change of
Alternative compared with Constitutive exons. Positive and negative
values represents excess and depletion, respectively.
4946 Nucleic Acids Research, 2011,Vol.39, No. 12borders, we can try to better understand the effect of
SNVs on ESS by deﬁning a pattern of ESS gain or loss
with the emergence of a derived allele. To this end we
deﬁned the polarity of change by assuming the reference
chimpanzee genome as the ancestral allele, as done by
others (29).
Results in Table 4 conﬁrm that exon skipping does not
seem to be primarily regulated by SNVs that create ESSs.
When we independently analyzed the events of ESS gain
from non-ESR motifs, the difference between case and
control sets does not exist (11 SNVs in the
isoform-associated set against 12 SNVs in the control
set, P-value=0.56). The difference is restricted to those
events of ESS gain from an ancestral ESE (29 SNVs in the
case set against 44 SNVs in the control set,
P-value=0.99). This suggests that the signiﬁcant deple-
tion of SNVs involved in ESS gain observed for this type
of alternative splicing reﬂects depletion in the number of
SNVs that affect ESEs.
These ﬁndings differ from those of Woolfe et al. (28),
and show that the mechanism of splicing regulation
among the skipped exons is more complex than just an
increase in the proportion of ESS gains. We note,
however, that these authors compared SNVs alleles
associated to skipped exons to a group of SNVs alleles
belonging to a heterogeneous set of exons. This differs
from our approach, in which the isoform-associated and
control SNVs alleles were all from skipped exons, and may
explain the differences between the studies.
For cryptic and intron retention, the predominant
pattern involves loss and alteration/maintenance of ESS.
Based on the signiﬁcant frequency of ESS loss, we predict
that the derived allele could be generating a decrease in
ESS strength in those cases where ESS is maintained.
Final remarks
The results reported here support the view that ESRs have
a higher genetic diversity in alternative exons when
compared to constitutive exons. We believe that this
genetic variation could to some extent be one of the
major features distinguishing alternative from constitutive
splicing. Furthermore, we provide evidence that this effect
is mainly due through SNVs acting on ESS.
A possible caveat of our approach is that we cannot
directly distinguish between causal and associated SNVs
since an isoform-associated SNV may be in linkage dis-
equilibrium with a different causal variant. However, our
re-sampling analysis addresses this issue by examining if
the isoform associated SNVs are associated to ESRs as
frequently as non-isoform associated SNVs (used as a
‘control’). Using this approach we were able to show
that ESS are signiﬁcantly overrepresented among
isoform-associated SNVs, supporting their functional
role in splicing regulation.
The emergence of next generation sequencing is begin-
ning to provide a huge amount of both genomic and ex-
pressed sequence data. We believe that the strategy used in
this manuscript will be very useful in the next few years to
further explore the role of SNVs in alternative splicing.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
Table 3. Difference in ESR densities between experimental and
control sets of SNVs
ESR Exon group P-value
Enhancers
RESCUE Skipping 0.74
Retention 0.87
Cryptic 0.98
a
Alternative 1
a
SC35 Skipping 0.95
a
Retention 1
a
Cryptic 0.85
Alternative 1
a
SRP40 Skipping 0.86
Retention 0.99
a
Cryptic 0.87
Alternative 0.9
SRP55 Skipping 0.19
Retention 0.86
Cryptic 0.44
Alternative 0.46
PESE Skipping 0.11
Retention 1
a
Cryptic 1
a
Alternative 1
a
SF2_IgM Skipping 0.09
Retention 1
a
Cryptic 0.93
Alternative 1
a
Silencers
PESS Skipping 0.92
Retention 0
b
Cryptic 0
b
Alternative 0
b
ESS Skipping 0.1
Retention 0.09
Cryptic 0.01
b
Alternative 0
b
aSigniﬁcantly lower than control.
bSigniﬁcantly higher than control.
Table 4. SNP counts of ESS loss, gain and maintenance found in
isoform-associated SNV data set and control data set
Isoform-associated
SNV set
Control
# P-value
Skipping
ESS loss 38 23–63 0.67
ESS gain 40 40–57 0.99
a
ESS maintenance 22 10–45 0.6
Cryptic
ESS loss 81 39–87 0.005
b
ESS gain 68 51–115 0.97
a
ESS maintenance 54 19–60 0.005
b
Intron retention
ESS loss 111 63–115 0.01
b
ESS gain 108 75–140 0.53
ESS maintenance 90 43–93 0
b
#Range for 1000 replicate data sets.
aSigniﬁcantly lower than the control.
bSigniﬁcantly higher than the control.
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